Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
UBS
US Department of Justice
Fuji
Federal Trade Commission
Accenture
Colorcon
AstraZeneca
McKinsey
Julphar

Generated: January 21, 2018

DrugPatentWatch Database Preview

MONTELUKAST SODIUM Drug Profile

« Back to Dashboard

Which patents cover Montelukast Sodium, and what generic alternatives are available?

Montelukast Sodium is a drug marketed by Ajanta Pharma Ltd, Dr Reddys Labs Ltd, Mylan Pharms Inc, Teva Pharms, Anbison Lab Co Ltd, Apotex Inc, Aurobindo Pharma Ltd, Cspc Ouyi Pharm Co, Hetero Labs Ltd V, Jubilant Generics, Kremers Urban Pharms, Macleods Pharms Ltd, Sandoz Inc, Torrent Pharms Ltd, Unimark Remedies Ltd, Vintage Pharms Llc, West-ward Pharms Int, Accord Hlthcare, Amneal Pharms, Apotex Corp, Cipla Ltd, Glenmark Generics, Perrigo R And D, and Unichem Labs Ltd. and is included in forty-three NDAs.

The generic ingredient in MONTELUKAST SODIUM is montelukast sodium. There are thirty-three drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the montelukast sodium profile page.

US Patents and Regulatory Information for MONTELUKAST SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms MONTELUKAST SODIUM montelukast sodium TABLET;ORAL 204604-001 Sep 4, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Torrent Pharms Ltd MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 090984-002 Aug 3, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hetero Labs Ltd V MONTELUKAST SODIUM montelukast sodium TABLET;ORAL 202843-001 Sep 10, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int MONTELUKAST SODIUM montelukast sodium TABLET;ORAL 090655-001 Aug 3, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cipla Ltd MONTELUKAST SODIUM montelukast sodium TABLET;ORAL 207463-001 Oct 28, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kremers Urban Pharms MONTELUKAST SODIUM montelukast sodium TABLET;ORAL 201522-001 Aug 3, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms MONTELUKAST SODIUM montelukast sodium TABLET;ORAL 078605-001 Aug 3, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 091414-002 Aug 3, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unimark Remedies Ltd MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 203037-001 Oct 30, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 078723-001 Aug 3, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Cipla
Medtronic
Novartis
Cerilliant
McKinsey
Cantor Fitzgerald
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot